News Focus
News Focus
icon url

drkazmd65

11/20/16 11:21 AM

#126938 RE: Trendliner #126936

Would you agree that the failure of NNVC to reach any of its previously stated milestones would require a significant downward adjustment in the probability of future success?


I would argue that the market has already weighed in on NNVC's issues in getting milestones done to this point.

This is one of the big reasons the stock has spent most of the last couple of years mostly trading less than $2/share.

However, since I view this lack of success to date as mostly already built into the current market value here, I view where we are today and for the last couple of years as the baseline they will build from once something does move forward.

I think that the probability of future success is based on what we see now. A fully functional pilot plant. A target disease that has a big potential market. The ability (assuming one believes management) to make sufficient quantity of that compound to actually get into clinical testing. Enough cash on hand to run at least until the end of 2017, and a timeline that should get them into clinical testing before that point,....

With all that in place NOW - I think that all that is needed is for NNVC to move forward and the market will respond accordingly. In other words, I see the downward 'adjustment' you allude to as already built in.

icon url

Rawnoc

11/20/16 1:28 PM

#126943 RE: Trendliner #126936

When it comes to biowrecks scams like NNVC, sticking to savvy analysis is better than sticking to known facts.